Brazzolotto X, Courcelle S, Sauvanet C, Guillon V, Igert A, Kononchik J, Nachon F, Ceppa F, Delacour H (2021)
Characterization of four BCHE mutations associated with prolonged effect of suxamethonium
Pharmacogenomics J 21(2):165-173:

Millet C, Plaud B, Delacour H (2021)
Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: a four-year experience
Anaesth Crit Care Pain Med

Lefrere B, Servonnet A, Ceppa F, Dorandeu F, Delacour H (2017)
Use of IFCC guidelines to verify acetylcholinesterase reference interval in adults determined with ChE check mobile testing system
Clinical Chemistry & Laboratory Medicine 55: e268

Schopfer LM, Delacour H, Masson P, Leroy J, Krejci E, Lockridge O (2017)
The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment
Molecules 22:

Delacour H, Dedome E, Courcelle S, Hary B, Ceppa F (2016)
Butyrylcholinesterase deficiency
Ann Biol Clin (Paris) 74: 279

Mabboux I, Hary B, Courcelle S, Ceppa F, Delacour H (2016)
[Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency]
Arch Pediatr 23: 497

Lushchekina SV, Delacour H, Lockridge O, Masson P (2015)
Human butyrylcholinesterase polymorphism: Molecular modeling
Int J Risk Saf Med 27 Suppl 1: S80

Delacour H, Lushchekina SV, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P (2014)
Characterization of a Novel BCHE Silent Allele: Point Mutation (p.Val204Asp) Causes Loss of Activity and Prolonged Apnea with Suxamethonium
PLoS ONE 9: e101552

Delacour H, Lushchekina SV, Mabboux I, Ceppa F, Masson P, Schopfer LM, Lockridge O (2014)
Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), silent with mivacurium
Biochemical Pharmacology 92: 476

Mabboux I, Dos Santos M, Courcelle S, Hary B, Ceppa F, Delacour H (2014)
Rapid detection of BCHE atypical variant (p.Asp70Gly) by high resolution melting curve analysis
Ann Biol Clin (Paris) 72: 543